Symbols / DMAAU Stock $10.58 +0.00% Drugs Made In America Acquisition Corp.

Financial Services • Shell Companies • United States • NGM
DMAAU (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Financial Services
Industry Shell Companies
CEO Mr. Roger Bendelac
Exch · Country NGM · United States
Market Cap 308.64M
Enterprise Value 356.73M
Income 5.94M
Sales —
FCF (ttm) -1.52M
Book/sh -0.21
Cash/sh 6,137.00
Employees —
Insider 10d —
IPO Jan 28, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B -49.21
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 0.02
Current Ratio 0.03
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -1.46%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 29.17M
Shs Float 27.31M
Insider Own 17.88%
Instit Own 2.60%
Short Float —
Short Ratio 15.75
Short Interest 1.50K
52W High 10.60
vs 52W High -0.23%
52W Low 10.16
vs 52W Low 4.09%
Beta —
Impl. Vol. —
Rel Volume 0.02
Avg Volume 49.00
Volume 1.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $10.58
Price $10.58
Change 0.00%
About

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$10.58
Latest analyst target
3. DCF / Fair value
$-0.94
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.58
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31
Total Revenue
0.00
Operating Revenue
0.00
Operating Expense
2.82
Selling General And Administration
2.82
General And Administrative Expense
2.82
Other Gand A
2.82
Total Expenses
2.82
Operating Income
-2.82
Total Operating Income As Reported
-2.82
EBITDA
-2.82
Normalized EBITDA
-2.82
EBIT
-2.82
Net Income
5.94
Pretax Income
5.94
Net Non Operating Interest Income Expense
8.76
Net Interest Income
8.76
Interest Income Non Operating
8.76
Interest Income
8.76
Tax Rate For Calcs
0.00
Tax Effect Of Unusual Items
0.00
Net Income Including Noncontrolling Interests
5.94
Net Income From Continuing Operation Net Minority Interest
5.94
Net Income From Continuing And Discontinued Operation
5.94
Net Income Continuous Operations
5.94
Normalized Income
5.94
Net Income Common Stockholders
5.94
Diluted NI Availto Com Stockholders
5.94
Line Item Trend 2025-12-31 2024-12-31
Total Assets
239.92
+43456.35%
0.55
Current Assets
0.01
+144.26%
0.00
Cash Cash Equivalents And Short Term Investments
0.01
+354.26%
0.00
Cash And Cash Equivalents
0.01
+354.26%
0.00
Cash Financial
0.01
+354.26%
0.00
Prepaid Assets
—
0.00
Other Current Assets
0.01
+66.32%
0.00
Total Non Current Assets
239.91
+43852.39%
0.55
Non Current Deferred Assets
0.00
-100.00%
0.55
Other Non Current Assets
239.91
—
Total Liabilities Net Minority Interest
7.28
+814.47%
0.80
Current Liabilities
0.38
-52.72%
0.80
Payables And Accrued Expenses
0.38
+182.10%
0.13
Payables
0.22
+187.51%
0.08
Accounts Payable
0.22
+187.51%
0.08
Current Accrued Expenses
0.15
+174.66%
0.06
Current Debt And Capital Lease Obligation
—
0.66
Current Debt
—
0.66
Other Current Borrowings
—
0.66
Total Non Current Liabilities Net Minority Interest
6.90
0.00
Tradeand Other Payables Non Current
6.90
0.00
Stockholders Equity
232.64
+95116.31%
-0.24
Common Stock Equity
232.64
+95116.31%
-0.24
Capital Stock
239.91
+24331312.58%
0.00
Common Stock
239.91
+24331312.58%
0.00
Preferred Stock
0.00
0.00
Share Issued
33.72
+10.70%
30.46
Ordinary Shares Number
33.72
+10.70%
30.46
Additional Paid In Capital
0.00
-100.00%
0.03
Retained Earnings
-7.27
-2496.10%
-0.28
Total Equity Gross Minority Interest
232.64
+95116.31%
-0.24
Total Capitalization
232.64
+95116.31%
-0.24
Working Capital
-0.36
+53.97%
-0.79
Invested Capital
232.64
+55625.60%
0.42
Total Debt
—
0.66
Net Debt
—
0.66
Net Tangible Assets
232.64
+95116.31%
-0.24
Tangible Book Value
232.64
+95116.31%
-0.24
Line Item Trend 2025-12-31
Operating Cash Flow
-0.54
Cash Flow From Continuing Operating Activities
-0.54
Net Income From Continuing Operations
5.94
Other Non Cash Items
-6.62
Change In Working Capital
0.14
Change In Prepaid Assets
-0.01
Change In Payables And Accrued Expense
0.14
Change In Payable
0.14
Change In Account Payable
0.14
Investing Cash Flow
-231.15
Cash Flow From Continuing Investing Activities
-231.15
Net Other Investing Changes
-231.15
Financing Cash Flow
231.69
Cash Flow From Continuing Financing Activities
231.69
Net Issuance Payments Of Debt
-0.90
Issuance Of Debt
0.00
Repayment Of Debt
-0.90
Short Term Debt Issuance
0.00
Short Term Debt Payments
-0.90
Net Short Term Debt Issuance
-0.90
Net Common Stock Issuance
232.05
Net Other Financing Charges
0.54
Changes In Cash
0.00
Beginning Cash Position
0.00
End Cash Position
0.01
Free Cash Flow
-0.54
Common Stock Issuance
232.05
Issuance Of Capital Stock
232.05
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category